KLS-13019 is a Cannabidiol-Derived Neuroprotective Agent with Improved Potency, Safety, and Permeability. (EC50=40nM; T1=7500). KLS-13019 was 50-fold more potent and >400-fold safer than cannabidiol and exhibited an in vitro profile consistent with imp
KISS1-305, the Metastin Kisspeptin analog, is a prototype peptide and chemical probe with suboptimal KISS1R agonistic activity and resistance to plasma protease degradation.